Sigurdur O Olafsson
CIK 1499481 · President and CEO · last filed 2026-02-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
4
Total Filings
28
Lifetime Open-Market Net
$25.1K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Keenova Therapeutics plc (MNK) Delisted | President and CEO | 189,863 | $0.34 | $64.6K | $25.1K | 4 | 2023-06-26 |
| Pfenex Inc. (PFNX) Delisted | Director | — | — | — | $0 | 3 | 2019-05-10 |
| ACT | Pres.-Global Generics | 0 | $42.41 | $0 | $0 | 1 | 2013-10-02 |
| Actavis, Inc. (WPI) Delisted | Pres-Global Generics | 68,163 | — | — | $0 | 5 | 2012-11-02 |
Recent Filings · Page 2 of 3
28 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-03-15 | Keenova Therapeutics plc (MNK) Delisted | Buy (P) | +3,000 | $25.1K | EDGAR |
| 2022-12-22 | Keenova Therapeutics plc (MNK) Delisted | Grant (A) | +225,272 | $0 | EDGAR |
| 2019-05-10 | Pfenex Inc. (PFNX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-05-10 | Pfenex Inc. (PFNX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-05-08 | Pfenex Inc. (PFNX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2013-11-13 | — | Sell (S) | −25,000 | -$4.00M | |
| 2013-10-03 | — | Grant (A) | +96,947 | $0 | |
| 2013-10-02 | ACT | Mixed | −84,643 | -$13.16M | EDGAR |
| 2013-08-13 | — | Sell (S) | −4,500 | -$609.6K | |
| 2013-08-06 | — | Tax (F) | −4,500 | -$609.6K |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.